Department of Health

Immunoglobulin (Ig) replacement therapy

The National Blood Authority (NBA) manages the appropriate use of Ig in Australia in accordance with the approved indications set out in the criteria. This is applicable for both intravenous (IV) and subcutaneous (SC) immunoglobulins.

The criteria for immunoglobulin use in Australia is only available online and can be found at National Blood Authority website.

The National Blood Authority has introduced the supply and governance structure to address the continued growth in demand for IVIg aimed at ensuring equity and sustainability of this resource.

Reviewed 21 September 2020

Health.vic

Was this page helpful?